Flexion Therapeutics, Inc.
FLXN
FLXN was delisted on the 18th of November, 2021.
94 hedge funds and large institutions have $434M invested in Flexion Therapeutics, Inc. in 2016 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 47 increasing their positions, 17 reducing their positions, and 9 closing their positions.
176% more repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 17
127% more call options, than puts
Call options by funds: $4.03M | Put options by funds: $1.78M
122% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 9
17% more capital invested
Capital invested by funds: $370M → $434M (+$64.3M)
12% more funds holding
Funds holding: 84 → 94 (+10)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
+$13.6M |
| 2 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$7.51M |
| 3 |
Bank of New York Mellon
New York
|
+$6.06M |
| 4 |
KCM
Kingdon Capital Management
New York
|
+$5.96M |
| 5 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
+$5.73M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$6.85M |
| 2 |
Allianz Asset Management
Munich,
Germany
|
-$1.92M |
| 3 |
WSA
Wall Street Associates
Lajolla,
California
|
-$1.07M |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$827K |
| 5 |
HCM
Highbridge Capital Management
New York
|
-$769K |
FLXN Hedge Fund Activity: Q4 2016 in Review
94 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in Flexion Therapeutics, Inc. (FLXN) for Q4 2016, worth a combined $434M — up 17% from $370M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new FLXN positions and 9 closed out — a net gain of 11 holders — while 47 added to existing stakes and 17 trimmed.
The largest buyer was Capital World Investors, adding an estimated $13.6M. The largest seller was Driehaus Capital Management, cutting an estimated $6.85M.
- 94 institutional investors held Flexion Therapeutics, Inc. (FLXN) as of Q4 2016, up from 84 in Q3 2016.
- Funds reported $434M of Flexion Therapeutics, Inc. stock for Q4 2016, up 17% quarter-over-quarter.
- 20 funds opened new Flexion Therapeutics, Inc. positions in Q4 2016 and 9 closed out, a net change of +11 holders.
- The largest Flexion Therapeutics, Inc. buyer in Q4 2016 was Capital World Investors, an estimated $13.6M added.
- The largest Flexion Therapeutics, Inc. seller in Q4 2016 was Driehaus Capital Management, an estimated $6.85M sold.
Based on aggregated 13F filings for Q4 2016.